Status:
COMPLETED
Silymarin Bioavailability Study
Lead Sponsor:
Isura
Conditions:
Bioavailability and Pharmacokinetics
Eligibility:
All Genders
21-65 years
Phase:
NA
Brief Summary
This study seeks to evaluate and compare the pharmacokinetics of a novel micellar silymarin formulation with that of a standard silymarin formulation.
Eligibility Criteria
Inclusion
- Male or female aged 21- 65 years
- Healthy, good physical condition
- Voluntary, written, informed consent to participate in the study.
Exclusion
- Serious acute or chronic diseases e.g. liver, kidney, or gastrointestinal diseases
- Contraindication or allergies to milk thistle
- Pregnancy or breastfeeding
- Concurrent use of supplements and/or medications
- Participation in another investigational study
Key Trial Info
Start Date :
May 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2025
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT06882681
Start Date
May 1 2024
End Date
January 31 2025
Last Update
March 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
ISURA
Burnaby, British Columbia, Canada, V2N 4S9